世界のNASH治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global NASH Therapeutic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4551 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、NASH治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンE＆ピオグリタゾン、オカリバ、エラフィブラノール、セロンセルチブ＆セニクリビロク）、用途別市場規模（病院薬局、オンラインプロバイダー、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・NASH治療薬の市場動向 ・企業の競争状況、市場シェア ・NASH治療薬の種類別市場規模と予測2016-2027（ビタミンE＆ピオグリタゾン、オカリバ、エラフィブラノール、セロンセルチブ＆セニクリビロク） ・NASH治療薬の用途別市場規模と予測2016-2027（病院薬局、オンラインプロバイダー、小売薬局） ・NASH治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・NASH治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・NASH治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・NASH治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・NASH治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan Plc (Tobira)、Bristol Myers Squibb、Galmed Pharmaceuticals、Genfit SA、Gilead Sciences, Inc.、Intercept Pharmaceuticals, Inc.、Zydus Cadila） ・結論

Market Analysis and Insights: Global NASH Therapeutic Drugs Market
The global NASH Therapeutic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NASH Therapeutic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NASH Therapeutic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NASH Therapeutic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NASH Therapeutic Drugs market.

Global NASH Therapeutic Drugs Scope and Market Size
NASH Therapeutic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NASH Therapeutic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib and Cenicriviroc

Segment by Application
Hospital Pharmacy
Online Provider
Retail Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NASH Therapeutic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vitamin E and Pioglitazone
1.2.3 Ocaliva
1.2.4 Elafibranor
1.2.5 Selonsertib and Cenicriviroc
1.3 Market by Application
1.3.1 Global NASH Therapeutic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Online Provider
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global NASH Therapeutic Drugs Market Perspective (2016-2027)
2.2 NASH Therapeutic Drugs Growth Trends by Regions
2.2.1 NASH Therapeutic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NASH Therapeutic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 NASH Therapeutic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 NASH Therapeutic Drugs Industry Dynamic
2.3.1 NASH Therapeutic Drugs Market Trends
2.3.2 NASH Therapeutic Drugs Market Drivers
2.3.3 NASH Therapeutic Drugs Market Challenges
2.3.4 NASH Therapeutic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top NASH Therapeutic Drugs Players by Revenue
3.1.1 Global Top NASH Therapeutic Drugs Players by Revenue (2016-2021)
3.1.2 Global NASH Therapeutic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global NASH Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NASH Therapeutic Drugs Revenue
3.4 Global NASH Therapeutic Drugs Market Concentration Ratio
3.4.1 Global NASH Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NASH Therapeutic Drugs Revenue in 2020
3.5 NASH Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players NASH Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into NASH Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NASH Therapeutic Drugs Breakdown Data by Type
4.1 Global NASH Therapeutic Drugs Historic Market Size by Type (2016-2021)
4.2 Global NASH Therapeutic Drugs Forecasted Market Size by Type (2022-2027)

5 NASH Therapeutic Drugs Breakdown Data by Application
5.1 Global NASH Therapeutic Drugs Historic Market Size by Application (2016-2021)
5.2 Global NASH Therapeutic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America NASH Therapeutic Drugs Market Size (2016-2027)
6.2 North America NASH Therapeutic Drugs Market Size by Type
6.2.1 North America NASH Therapeutic Drugs Market Size by Type (2016-2021)
6.2.2 North America NASH Therapeutic Drugs Market Size by Type (2022-2027)
6.2.3 North America NASH Therapeutic Drugs Market Size by Type (2016-2027)
6.3 North America NASH Therapeutic Drugs Market Size by Application
6.3.1 North America NASH Therapeutic Drugs Market Size by Application (2016-2021)
6.3.2 North America NASH Therapeutic Drugs Market Size by Application (2022-2027)
6.3.3 North America NASH Therapeutic Drugs Market Size by Application (2016-2027)
6.4 North America NASH Therapeutic Drugs Market Size by Country
6.4.1 North America NASH Therapeutic Drugs Market Size by Country (2016-2021)
6.4.2 North America NASH Therapeutic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe NASH Therapeutic Drugs Market Size (2016-2027)
7.2 Europe NASH Therapeutic Drugs Market Size by Type
7.2.1 Europe NASH Therapeutic Drugs Market Size by Type (2016-2021)
7.2.2 Europe NASH Therapeutic Drugs Market Size by Type (2022-2027)
7.2.3 Europe NASH Therapeutic Drugs Market Size by Type (2016-2027)
7.3 Europe NASH Therapeutic Drugs Market Size by Application
7.3.1 Europe NASH Therapeutic Drugs Market Size by Application (2016-2021)
7.3.2 Europe NASH Therapeutic Drugs Market Size by Application (2022-2027)
7.3.3 Europe NASH Therapeutic Drugs Market Size by Application (2016-2027)
7.4 Europe NASH Therapeutic Drugs Market Size by Country
7.4.1 Europe NASH Therapeutic Drugs Market Size by Country (2016-2021)
7.4.2 Europe NASH Therapeutic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific NASH Therapeutic Drugs Market Size (2016-2027)
8.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type
8.2.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application
8.3.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific NASH Therapeutic Drugs Market Size by Region
8.4.1 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America NASH Therapeutic Drugs Market Size (2016-2027)
9.2 Latin America NASH Therapeutic Drugs Market Size by Type
9.2.1 Latin America NASH Therapeutic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America NASH Therapeutic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America NASH Therapeutic Drugs Market Size by Type (2016-2027)
9.3 Latin America NASH Therapeutic Drugs Market Size by Application
9.3.1 Latin America NASH Therapeutic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America NASH Therapeutic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America NASH Therapeutic Drugs Market Size by Application (2016-2027)
9.4 Latin America NASH Therapeutic Drugs Market Size by Country
9.4.1 Latin America NASH Therapeutic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America NASH Therapeutic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa NASH Therapeutic Drugs Market Size (2016-2027)
10.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type
10.2.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application
10.3.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa NASH Therapeutic Drugs Market Size by Country
10.4.1 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan Plc (Tobira)
11.1.1 Allergan Plc (Tobira) Company Details
11.1.2 Allergan Plc (Tobira) Business Overview
11.1.3 Allergan Plc (Tobira) NASH Therapeutic Drugs Introduction
11.1.4 Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.1.5 Allergan Plc (Tobira) Recent Development
11.2 Bristol Myers Squibb
11.2.1 Bristol Myers Squibb Company Details
11.2.2 Bristol Myers Squibb Business Overview
11.2.3 Bristol Myers Squibb NASH Therapeutic Drugs Introduction
11.2.4 Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.2.5 Bristol Myers Squibb Recent Development
11.3 Galmed Pharmaceuticals
11.3.1 Galmed Pharmaceuticals Company Details
11.3.2 Galmed Pharmaceuticals Business Overview
11.3.3 Galmed Pharmaceuticals NASH Therapeutic Drugs Introduction
11.3.4 Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.3.5 Galmed Pharmaceuticals Recent Development
11.4 Genfit SA
11.4.1 Genfit SA Company Details
11.4.2 Genfit SA Business Overview
11.4.3 Genfit SA NASH Therapeutic Drugs Introduction
11.4.4 Genfit SA Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.4.5 Genfit SA Recent Development
11.5 Gilead Sciences, Inc.
11.5.1 Gilead Sciences, Inc. Company Details
11.5.2 Gilead Sciences, Inc. Business Overview
11.5.3 Gilead Sciences, Inc. NASH Therapeutic Drugs Introduction
11.5.4 Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.5.5 Gilead Sciences, Inc. Recent Development
11.6 Intercept Pharmaceuticals, Inc.
11.6.1 Intercept Pharmaceuticals, Inc. Company Details
11.6.2 Intercept Pharmaceuticals, Inc. Business Overview
11.6.3 Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Introduction
11.6.4 Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.6.5 Intercept Pharmaceuticals, Inc. Recent Development
11.7 Zydus Cadila
11.7.1 Zydus Cadila Company Details
11.7.2 Zydus Cadila Business Overview
11.7.3 Zydus Cadila NASH Therapeutic Drugs Introduction
11.7.4 Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2016-2021)
11.7.5 Zydus Cadila Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global NASH Therapeutic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vitamin E and Pioglitazone
Table 3. Key Players of Ocaliva
Table 4. Key Players of Elafibranor
Table 5. Key Players of Selonsertib and Cenicriviroc
Table 6. Global NASH Therapeutic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global NASH Therapeutic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global NASH Therapeutic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global NASH Therapeutic Drugs Market Share by Regions (2016-2021)
Table 10. Global NASH Therapeutic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global NASH Therapeutic Drugs Market Share by Regions (2022-2027)
Table 12. NASH Therapeutic Drugs Market Trends
Table 13. NASH Therapeutic Drugs Market Drivers
Table 14. NASH Therapeutic Drugs Market Challenges
Table 15. NASH Therapeutic Drugs Market Restraints
Table 16. Global NASH Therapeutic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global NASH Therapeutic Drugs Market Share by Players (2016-2021)
Table 18. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2020)
Table 19. Ranking of Global Top NASH Therapeutic Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by NASH Therapeutic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players NASH Therapeutic Drugs Product Solution and Service
Table 23. Date of Enter into NASH Therapeutic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global NASH Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global NASH Therapeutic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global NASH Therapeutic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global NASH Therapeutic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global NASH Therapeutic Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global NASH Therapeutic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global NASH Therapeutic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific NASH Therapeutic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa NASH Therapeutic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa NASH Therapeutic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa NASH Therapeutic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. Allergan Plc (Tobira) Company Details
Table 64. Allergan Plc (Tobira) Business Overview
Table 65. Allergan Plc (Tobira) NASH Therapeutic Drugs Product
Table 66. Allergan Plc (Tobira) Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 67. Allergan Plc (Tobira) Recent Development
Table 68. Bristol Myers Squibb Company Details
Table 69. Bristol Myers Squibb Business Overview
Table 70. Bristol Myers Squibb NASH Therapeutic Drugs Product
Table 71. Bristol Myers Squibb Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 72. Bristol Myers Squibb Recent Development
Table 73. Galmed Pharmaceuticals Company Details
Table 74. Galmed Pharmaceuticals Business Overview
Table 75. Galmed Pharmaceuticals NASH Therapeutic Drugs Product
Table 76. Galmed Pharmaceuticals Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 77. Galmed Pharmaceuticals Recent Development
Table 78. Genfit SA Company Details
Table 79. Genfit SA Business Overview
Table 80. Genfit SA NASH Therapeutic Drugs Product
Table 81. Genfit SA Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 82. Genfit SA Recent Development
Table 83. Gilead Sciences, Inc. Company Details
Table 84. Gilead Sciences, Inc. Business Overview
Table 85. Gilead Sciences, Inc. NASH Therapeutic Drugs Product
Table 86. Gilead Sciences, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 87. Gilead Sciences, Inc. Recent Development
Table 88. Intercept Pharmaceuticals, Inc. Company Details
Table 89. Intercept Pharmaceuticals, Inc. Business Overview
Table 90. Intercept Pharmaceuticals, Inc. NASH Therapeutic Drugs Product
Table 91. Intercept Pharmaceuticals, Inc. Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 92. Intercept Pharmaceuticals, Inc. Recent Development
Table 93. Zydus Cadila Company Details
Table 94. Zydus Cadila Business Overview
Table 95. Zydus Cadila NASH Therapeutic Drugs Product
Table 96. Zydus Cadila Revenue in NASH Therapeutic Drugs Business (2016-2021) & (US$ Million)
Table 97. Zydus Cadila Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NASH Therapeutic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Vitamin E and Pioglitazone Features
Figure 3. Ocaliva Features
Figure 4. Elafibranor Features
Figure 5. Selonsertib and Cenicriviroc Features
Figure 6. Global NASH Therapeutic Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Online Provider Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. NASH Therapeutic Drugs Report Years Considered
Figure 11. Global NASH Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global NASH Therapeutic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global NASH Therapeutic Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global NASH Therapeutic Drugs Market Share by Regions (2022-2027)
Figure 15. Global NASH Therapeutic Drugs Market Share by Players in 2020
Figure 16. Global Top NASH Therapeutic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NASH Therapeutic Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by NASH Therapeutic Drugs Revenue in 2020
Figure 18. Global NASH Therapeutic Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global NASH Therapeutic Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America NASH Therapeutic Drugs Market Share by Type (2016-2027)
Figure 22. North America NASH Therapeutic Drugs Market Share by Application (2016-2027)
Figure 23. North America NASH Therapeutic Drugs Market Share by Country (2016-2027)
Figure 24. United States NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe NASH Therapeutic Drugs Market Share by Type (2016-2027)
Figure 28. Europe NASH Therapeutic Drugs Market Share by Application (2016-2027)
Figure 29. Europe NASH Therapeutic Drugs Market Share by Country (2016-2027)
Figure 30. Germany NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific NASH Therapeutic Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific NASH Therapeutic Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific NASH Therapeutic Drugs Market Share by Region (2016-2027)
Figure 40. China NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America NASH Therapeutic Drugs Market Share by Type (2016-2027)
Figure 48. Latin America NASH Therapeutic Drugs Market Share by Application (2016-2027)
Figure 49. Latin America NASH Therapeutic Drugs Market Share by Country (2016-2027)
Figure 50. Mexico NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa NASH Therapeutic Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa NASH Therapeutic Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa NASH Therapeutic Drugs Market Share by Country (2016-2027)
Figure 56. Turkey NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE NASH Therapeutic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Allergan Plc (Tobira) Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 60. Bristol Myers Squibb Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 61. Galmed Pharmaceuticals Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 62. Genfit SA Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 63. Gilead Sciences, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 64. Intercept Pharmaceuticals, Inc. Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 65. Zydus Cadila Revenue Growth Rate in NASH Therapeutic Drugs Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---